Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease
Journal of Alzheimer's Disease · 2024
DOI: 10.3233/jad-240497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Pietro Gareri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Frailty, Center of Cognitive Impairment and Dementia, Catanzaro Lido, ASP Catanzaro, Catanzaro Lido, Italy. Hauptthemen laut MEDLINE: Cytidine Diphosphate Choline, Memantine, Cholinesterase Inhibitors, Alzheimer Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Citicoline is a naturally occurring compound with pleiotropic effects on neuronal function and cognitive processes.
Objective
Based on previous studies, which shed light on the positive effects of citicoline 1 g when combined with acetylcholinesterase inhibitors (AChEIs) and/or memantine, we further investigated the benefits of citicoline in combination therapy in Alzheimer’s disease and mixed dementia.
Methods
We integrated the datasets of CITIMEM and CITIDEMAGE, increasing the overall sample size to enhance statistical power. We analyzed data from these two investigator-initiated studies involving 295 patients. The primary outcome was the assessment over time of the effects of combined treatment versus memantine given alone or AChEI plus memantine on cognitive functions assessed by Mini-Mental State Examination (MMSE). The secondary outcomes were the influence of combined treatment on daily life functions, mood, and behavioral symptoms assessed by activities of daily life (ADL) and instrumental ADL, Geriatric Depression Scale, and Neuropsychiatric Inventory Scale. One-hundred-forty-three patients were treated with memantine and/or AChEI (control group), and 152 patients were treated with memantine and/or AChEI plus citicoline 1 g/day orally (Citicoline group).
Results
A significant difference in MMSE score was found in the average between the two groups of treatment at 6 and 12 months.
Conclusions
This study confirmed the effectiveness of combined citicoline treatment in patients with mixed dementia and Alzheimer’s disease, with a significant effect on the increase of MMSE score over time. The treated group also showed a significant reduction in the Geriatric Depression Scale and a significant increase in the instrumental ADL scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Frailty, Center of Cognitive Impairment and Dementia, Catanzaro Lido, ASP Catanzaro, Catanzaro Lido, Italy.
- Director Complex Geriatric Unit, Maria Vittoria Hospital, Turin, Italy.
- Medical Affairs, Piam Farmaceutici S.p.A, Genoa, Italy.
- Geriatrician, Naples, Italy.
Zitieren
APA
Gareri, P., Cotroneo, A. M., Montella, R., Gaglianone, M., & Putignano, S. (2024). Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-240497
Vancouver
Gareri P, Cotroneo AM, Montella R, Gaglianone M, Putignano S. Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-240497
BibTeX
@article{Gareri2024,
author = {Gareri, Pietro and Cotroneo, Antonino Maria and Montella, Roberta and Gaglianone, Matteo and Putignano, Salvatore},
title = {Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease},
journal = {Journal of Alzheimer's Disease},
year = {2024},
doi = {10.3233/jad-240497}
}
EUVIMED